Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-11

FDA Approved: TESTOSTERONE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a supplemental application for TESTOSTERONE by Alembic Pharmaceuticals Inc., authorizing changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

SUPPL AP for TESTOSTERONE (TESTOSTERONE)